Annual Shareholders Equity
$173.59 M
-$151.65 M-46.63%
December 31, 2023
Summary
- As of February 8, 2025, BVS annual stockholders equity is $173.59 million, with the most recent change of -$151.65 million (-46.63%) on December 31, 2023.
- During the last 3 years, BVS annual shareholders equity has risen by +$29.43 million (+20.42%).
- BVS annual shareholders equity is now -62.17% below its all-time high of $458.92 million, reached on December 31, 2021.
Performance
BVS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$148.74 M
-$2.20 M-1.46%
September 28, 2024
Summary
- As of February 8, 2025, BVS quarterly stockholders equity is $148.74 million, with the most recent change of -$2.20 million (-1.46%) on September 28, 2024.
- Over the past year, BVS quarterly shareholders equity has dropped by -$24.85 million (-14.32%).
- BVS quarterly shareholders equity is now -67.59% below its all-time high of $458.92 million, reached on December 31, 2021.
Performance
BVS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
BVS Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -46.6% | -14.3% |
3 y3 years | +20.4% | -67.6% |
5 y5 years | +19.5% | -67.6% |
BVS Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -62.2% | at low | -67.6% | at low |
5 y | 5-year | -62.2% | +21.4% | -67.6% | +5.1% |
alltime | all time | -62.2% | +21.4% | -67.6% | +5.1% |
Bioventus Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $148.74 M(-1.5%) |
Jun 2024 | - | $150.94 M(-11.9%) |
Mar 2024 | - | $171.28 M(-1.3%) |
Dec 2023 | $173.59 M(-46.6%) | $173.59 M(-2.2%) |
Sep 2023 | - | $177.53 M(-3.1%) |
Jun 2023 | - | $183.19 M(-2.8%) |
Mar 2023 | - | $188.51 M(-42.0%) |
Dec 2022 | $325.24 M(-29.1%) | $325.24 M(-5.3%) |
Sep 2022 | - | $343.40 M(-23.3%) |
Jun 2022 | - | $447.98 M(-0.4%) |
Mar 2022 | - | $449.78 M(-2.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | $458.92 M(+218.3%) | $458.92 M(+200.9%) |
Sep 2021 | - | $152.50 M(+7.7%) |
Jun 2021 | - | $141.56 M(-0.6%) |
Mar 2021 | - | $142.39 M(-1.2%) |
Dec 2020 | $144.16 M(+0.8%) | $144.16 M(+0.7%) |
Sep 2020 | - | $143.22 M(+0.2%) |
Dec 2019 | $142.98 M(-1.6%) | $142.98 M(-23.3%) |
Dec 2018 | $145.27 M(-24.5%) | - |
Mar 2016 | - | $186.30 M |
Dec 2015 | $192.34 M(+8.4%) | - |
Dec 2014 | $177.49 M | - |
FAQ
- What is Bioventus annual stockholders equity?
- What is the all time high annual shareholders equity for Bioventus?
- What is Bioventus annual shareholders equity year-on-year change?
- What is Bioventus quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Bioventus?
- What is Bioventus quarterly shareholders equity year-on-year change?
What is Bioventus annual stockholders equity?
The current annual shareholders equity of BVS is $173.59 M
What is the all time high annual shareholders equity for Bioventus?
Bioventus all-time high annual stockholders equity is $458.92 M
What is Bioventus annual shareholders equity year-on-year change?
Over the past year, BVS annual stockholders equity has changed by -$151.65 M (-46.63%)
What is Bioventus quarterly stockholders equity?
The current quarterly shareholders equity of BVS is $148.74 M
What is the all time high quarterly shareholders equity for Bioventus?
Bioventus all-time high quarterly stockholders equity is $458.92 M
What is Bioventus quarterly shareholders equity year-on-year change?
Over the past year, BVS quarterly stockholders equity has changed by -$24.85 M (-14.32%)